• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GU 癌症中的保器官手术:第 1 部分-肾脏和肾上腺肿瘤中的保器官手术:系统评价。

Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.

机构信息

Department of Urology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Department of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

出版信息

Int Urol Nephrol. 2019 Mar;51(3):377-393. doi: 10.1007/s11255-018-02070-5. Epub 2019 Jan 8.

DOI:10.1007/s11255-018-02070-5
PMID:30623290
Abstract

PURPOSE

Organ-sparing surgery (OSS) for the kidney and adrenals has emerged as the need for preservation of function is paramount in patients with poor functional reserve. As reports increasingly showed that oncological outcomes were equivalent to radical excision, elective OSS became a viable alternative in patients with otherwise normal reserve. In this review, we summarize the current knowledge of OSS for adrenal and renal tumors.

MATERIALS AND METHODS

PubMed, Web of Science and Cochrane Library Central Search were searched for recently published articles up to December 2017. The following keywords were used; "partial adrenalectomy", "adrenal sparing", "partial nephrectomy", "nephron sparing", "kidney/renal cancer".

RESULTS

Partial adrenalectomy became an attractive alternative to total adrenalectomy avoiding adrenal insufficiency. Both minimally invasive surgery and ablative techniques were increasingly reported for adrenal OSS with adequate residual adrenal function and excellent oncological outcome. Radical nephrectomy remained for many years as the gold standard of treatment for organ-confined renal cell carcinoma. As the need to reduce the impact on renal function, more conservative approaches were utilized. Soon, the non-inferiority of nephron-sparing surgery to that of radical excision became evident and elective partial nephrectomy was gaining ground as the standard of care for small renal masses in patients with normal contralateral kidneys.

CONCLUSIONS

Herein, we present a comprehensive review of the current status of OSS in renal and adrenal tumors.

摘要

目的

在功能保存至关重要的患者中,保留器官的手术(OSS)已成为肾脏和肾上腺的首选治疗方法,因为这些患者的功能储备较差。随着越来越多的报告表明肿瘤学结果与根治性切除相当,选择性 OSS 成为了具有正常储备功能的患者的一种可行替代方法。在这篇综述中,我们总结了当前关于肾上腺和肾脏肿瘤 OSS 的知识。

材料和方法

我们在 PubMed、Web of Science 和 Cochrane Library Central Search 上搜索了截至 2017 年 12 月的最新发表的文章。使用了以下关键词:“部分肾上腺切除术”、“肾上腺保留”、“部分肾切除术”、“保留肾单位”、“肾脏/肾癌”。

结果

部分肾上腺切除术成为了避免肾上腺功能不全的总肾上腺切除术的一种有吸引力的替代方法。微创外科和消融技术越来越多地用于肾上腺 OSS,可保留足够的残留肾上腺功能并获得良好的肿瘤学结果。根治性肾切除术多年来一直是局限性肾细胞癌的金标准治疗方法。随着减少对肾功能影响的需求增加,更多的保守方法被采用。很快,保肾手术与根治性切除的非劣效性变得明显,对于对侧肾脏正常的小肾癌患者,选择性部分肾切除术作为标准治疗方法得到了广泛应用。

结论

本文全面回顾了肾脏和肾上腺肿瘤 OSS 的现状。

相似文献

1
Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.GU 癌症中的保器官手术:第 1 部分-肾脏和肾上腺肿瘤中的保器官手术:系统评价。
Int Urol Nephrol. 2019 Mar;51(3):377-393. doi: 10.1007/s11255-018-02070-5. Epub 2019 Jan 8.
2
Management of the adrenal gland during partial nephrectomy.肾部分切除术期间肾上腺的处理
J Urol. 2009 Jun;181(6):2430-6; discussion 2436-7. doi: 10.1016/j.juro.2009.02.027. Epub 2009 Apr 16.
3
Adrenal sparing surgery during radical nephrectomy in patients with renal cell cancer: a new algorithm.肾细胞癌患者根治性肾切除术中的保留肾上腺手术:一种新算法
J Urol. 2001 Jul;166(1):59-62.
4
Evolving trends in the surgical management of renal masses over the past two decades: A contemporary picture from a large prospectively-maintained database.过去二十年来,肾肿瘤外科治疗的演变趋势:一项来自大型前瞻性数据库的现代研究。
Int J Urol. 2019 Apr;26(4):465-474. doi: 10.1111/iju.13909. Epub 2019 Feb 28.
5
Laparoscopic upper pole partial nephrectomy with concomitant en bloc adrenalectomy.腹腔镜上极部分肾切除术联合整块肾上腺切除术
Urology. 2003 Aug;62(2):223-6. doi: 10.1016/s0090-4295(03)00366-2.
6
[Minimally invasive vs. open partial nephrectomy : Perioperative success and complication rates].[微创与开放性部分肾切除术:围手术期成功率及并发症发生率]
Urologe A. 2018 Jul;57(7):821-827. doi: 10.1007/s00120-018-0646-y.
7
Investigation on the indication of ipsilateral adrenalectomy in radical nephrectomy: a meta-analysis.根治性肾切除术中保留同侧肾上腺的适应证Meta 分析。
Chin Med J (Engl). 2012 Nov;125(21):3885-90.
8
Robot-assisted partial adrenalectomy for isolated adrenal metastasis.机器人辅助下孤立性肾上腺转移瘤的部分肾上腺切除术
J Endourol. 2009 Apr;23(4):651-4. doi: 10.1089/end.2008.0440.
9
Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors.临床T1b和T2期肾肿瘤行部分肾切除术的结果。
Curr Opin Urol. 2014 Sep;24(5):448-52. doi: 10.1097/MOU.0000000000000081.
10
Nephron sparing surgery for renal tumors: indications, techniques and outcomes.肾肿瘤的保留肾单位手术:适应证、技术及疗效
J Urol. 2001 Jul;166(1):6-18.

引用本文的文献

1
Treating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks.原发性醛固酮增多症相关性高血压的治疗:新方法与未来展望。
Endocr Rev. 2024 Jan 4;45(1):125-170. doi: 10.1210/endrev/bnad026.
2
Tailored Approach in Adrenal Surgery: Retroperitoneoscopic Partial Adrenalectomy.经腹腔鏡下部分腎上腺切除術:個體化治療方案。
Front Endocrinol (Lausanne). 2022 Mar 28;13:855326. doi: 10.3389/fendo.2022.855326. eCollection 2022.
3
Minimally Invasive Adrenal Surgery.微创肾上腺手术。

本文引用的文献

1
Ten-Year Outcomes of Renal Tumor Radio Frequency Ablation.肾肿瘤射频消融术的十年疗效。
J Urol. 2019 Feb;201(2):251-258. doi: 10.1016/j.juro.2018.08.045.
2
Available ablation energies to treat cT1 renal cell cancer: emerging technologies.可用于治疗 cT1 期肾细胞癌的消融能量:新兴技术。
World J Urol. 2019 Mar;37(3):445-455. doi: 10.1007/s00345-018-2546-6. Epub 2018 Nov 17.
3
Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
Endocrinol Metab (Seoul). 2020 Dec;35(4):774-783. doi: 10.3803/EnM.2020.404. Epub 2020 Dec 23.
4
Experience in the application of laparoscopic anatomical adrenalectomy via the renal cortex surface monolayer.经肾皮质表面单层腹腔镜解剖性肾上腺切除术的应用经验。
Pak J Med Sci. 2020 May-Jun;36(4):717-722. doi: 10.12669/pjms.36.4.2102.
影像引导下冷冻消融治疗散发性肾细胞癌:220 例经活检证实的肾细胞癌患者的 3 年和 5 年结果。
Radiology. 2018 Nov;289(2):554-561. doi: 10.1148/radiol.2018180249. Epub 2018 Aug 7.
4
Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study.T1b期肾细胞癌的射频消融与冷冻消融:一项多中心研究
Jpn J Radiol. 2018 Sep;36(9):551-558. doi: 10.1007/s11604-018-0756-x. Epub 2018 Jul 2.
5
Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis.经皮消融与部分和根治性肾切除术治疗 T1a 期肾癌:基于人群的分析。
Ann Intern Med. 2018 Jul 17;169(2):69-77. doi: 10.7326/M17-0585. Epub 2018 Jun 26.
6
SEER study of ablation versus partial nephrectomy in cT1A renal cell carcinoma.SEER 研究比较了 cT1A 期肾细胞癌的消融与部分肾切除术。
Future Oncol. 2018 Jul;14(17):1711-1719. doi: 10.2217/fon-2017-0678. Epub 2018 Jun 25.
7
Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.孤立性、散发性肾细胞癌的经皮冷冻消融:基于透明细胞与乳头状亚型的疗效分析
J Vasc Interv Radiol. 2018 Aug;29(8):1122-1126. doi: 10.1016/j.jvir.2018.02.029. Epub 2018 Jun 7.
8
Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.T1a 期肾细胞癌的热消融、手术切除与主动监测的疗效比较:监测、流行病学和最终结果(SEER)-医疗保险关联人群研究。
Radiology. 2018 Jul;288(1):81-90. doi: 10.1148/radiol.2018171407. Epub 2018 May 8.
9
The significance of predictable traumatic area by renorrhaphy in the prediction of postoperative ipsilateral renal function.肾缝合术中可预测创伤区域在预测术后同侧肾功能方面的意义。
Cent European J Urol. 2018;71(1):64-71. doi: 10.5173/ceju.2018.1557. Epub 2017 Jan 22.
10
Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.T1c期肾细胞癌的热消融:微波消融、射频消融和冷冻消融的技术性能、手术结果及安全性的比较评估
J Vasc Interv Radiol. 2018 Jul;29(7):943-951. doi: 10.1016/j.jvir.2017.12.020. Epub 2018 Apr 6.